EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis

Sevil Ceyhan Dogan iD, Kenan Goren iD

Biology · 18.06.2026 · 15 (12) · 952

DOI: 10.3390/biology15120952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology, online erschienen am 18.06.2026. Verfasst von Sevil Ceyhan Dogan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the structural, electronic, pharmacokinetic, and receptor-binding properties of three bisphosphonate derivatives, alendronate, risedronate, and zoledronate, to investigate their therapeutic relevance in osteoporosis and breast cancer. Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d,p) level showed that risedronate exhibited the highest kinetic stability (ΔE = 6.7468 eV), whereas zoledronate displayed greater chemical reactivity (ΔE = 2.9669 eV) and the strongest nonlinear optical response (β = 1.20 × 10−30 esu). ADMET analysis indicated acceptable safety profiles for all compounds, although high polarity and low lipophilicity may limit oral bioavailability. Molecular docking against 11 breast cancer- and bone metabolism-related targets revealed favorable binding affinities, particularly for zoledronate and risedronate. Zoledronate showed strong interactions with ESR2, VEGFR/KDR, GGPS1, and FPPS, whereas risedronate exhibited notable affinity for BRCA2 and MMP9. Bioinformatics analyses identified significant dysregulation of GGPS1, FDPS, TNFSF11, ESR1, MMP9, and BRCA2 in breast cancer tissues, while survival analysis linked elevated FDPS, MMP9, and BRCA2 expression to poor prognosis. Network analyses highlighted pathways related to mevalonate metabolism, hormone signaling, angiogenesis, extracellular matrix remodeling, and the RANK/RANKL/OPG axis. These findings support the potential repurposing of bisphosphonates, particularly zoledronate, for breast cancer-associated bone disease.

Schlagwörter

Stichwörter der Autor:innen

ADMETDFTbioinformaticsbisphosphonatesbreast cancergene expressionmolecular dockingosteoporosissurvival analysis

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey.
  • Department of Organic Chemistry, Faculty of Arts and Sciences, Kafkas University, Kars 36100, Turkey.

ORCID-Profile: Sevil Ceyhan Dogan, Kenan Goren

Zitieren

APA

Dogan, S. C., & Goren, K. (2026). The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis. Biology, 15(12), 952. https://doi.org/10.3390/biology15120952

Vancouver

Dogan SC, Goren K. The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis. Biology. 2026;15(12):952. doi:10.3390/biology15120952

BibTeX
@article{Dogan2026,
  author = {Dogan, Sevil Ceyhan and Goren, Kenan},
  title = {The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis},
  journal = {Biology},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {952},
  doi = {10.3390/biology15120952}
}
Kostenlos starten →